Target intelligence / Profile preview

Structure-directing agent (SDA)

Target
SDA
Molecular classification
Other
01

Overview

A structure-directing agent (SDA) is a chemical species, typically an organic cation or molecule, used in the synthesis of microporous and mesoporous materials such as zeolites and metal-organic frameworks (MOFs). According to the International Zeolite Association, these agents function by organizing inorganic building blocks into specific three-dimensional frameworks through non-covalent interactions like hydrogen bonding and van der Waals forces (Corma et al., 2004, 'Nature'). In the context of pharmacology and drug discovery, a structure-directing agent is not a biological receptor, enzyme, or therapeutic target within the human body. Instead, it is a tool in materials science used to engineer the architecture of materials that may eventually serve as drug delivery vehicles or catalysts. Because it lacks a biological role, there are no associated diseases, clinical biomarkers, or therapeutic drugs that target it in a physiological setting. Its primary utility remains in industrial and laboratory chemical synthesis (Davis et al., 2002, 'Nature').

Other names
TemplateTemplating agentOrganic structure-directing agentOSDAPore-directing agent
02

Mechanism of action

Not applicable as this is a chemical synthesis component, not a biological target.

03

Safety considerations

Environmental toxicity in manufacturingThermal decomposition during calcination

Beyond the preview

Go deeper on Structure-directing agent (SDA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Structure-directing agent (SDA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call